Immunespecific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent orolabial herpes simplex virus infections
- 1 July 1985
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 16 (3) , 297-305
- https://doi.org/10.1002/jmv.1890160311
Abstract
Immunespecific IFN (IFN) is produced by the peripheral blood mononuclear leukocytes (PBML) of greater than 95% of HSV-seropositive humans with infrequent recurrences of herpes labialis [Green, Yeh, and Overall, 1981]. However, herpes virus-induced immunespecific IFN was produced by PBML from only 33 of 48 (68.8%) persons with frequent recurrences (2–12 episodes a year). Two of eight subjects with primary herpes gingivostomatitis also failed to produce immunespecific IFN during either the acute or convalescent phases of their initial HSV infection. These data suggest that some persons have a defective immunespecific IFN response that exists from the time of their primary orolabial HSV type 1 infection. This defect may predispose to a higher frequency of disease in some individuals.Keywords
This publication has 23 references indexed in Scilit:
- More rapid isolation of herpes simplex virus in a continuous line of mink lung cells than in vero or human fibroblast cellsDiagnostic Microbiology and Infectious Disease, 1984
- Cellular Immune Response in Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1978
- Cell-Mediated Cytotoxicity in Recurrent Herpes Simplex Virus Infections in ManExperimental Biology and Medicine, 1977
- The Natural History of Recurrent Herpes Simplex LabialisNew England Journal of Medicine, 1977
- Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpes simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixationBritish Journal of Dermatology, 1975
- Cell-mediated Immunity to Herpes Simplex Virus in ManAmerican Journal of Clinical Pathology, 1973
- Cell-mediated Immunity in Herpesvirus hominis InfectionsBMJ, 1972